Bristol Myers Squibb (NYSE: BMY)
$58.00
(0.4%)
$0.24
Price as of December 26, 2024, 4:00 p.m. ET
Bristol Myers Squibb Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bristol Myers Squibb Company Info
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
News & Analysis
The Fool has written over 500 articles on Bristol Myers Squibb.
Featured Article
Got $250? 2 Healthcare Stocks to Buy and Hold Forever
Prosper Junior Bakiny | Dec 19, 2024
Featured Article
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
Eric Volkman | Dec 19, 2024
3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income
David Jagielski | Dec 17, 2024
Is Bristol-Myers Squibb Stock a Millionaire Maker?
Alex Carchidi | Dec 2, 2024
Where Will Bristol Myers Squibb Be in 5 Years?
Alex Carchidi | Nov 24, 2024
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
David Jagielski | Nov 21, 2024
Is Bristol Myers Squibb Stock a Buy?
Prosper Junior Bakiny | Nov 19, 2024
BMY Beats Analyst Estimates
JesterAI | Oct 31, 2024
Bristol Myers Squibb reported strong third-quarter financial results, notching an 18% jump in its growth portfolio.
Valuation
Podcast Episodes
The Top Biotech Stocks to Watch Following ASH 2019
The potential to reshape treatment of blood cancer and disorders could mean big bucks for these companies.
Todd Campbell | Dec 19, 2019
3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year
These stocks skyrocketed following exciting announcements.
Todd Campbell | Jan 10, 2019
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.